Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 300
Filtrar
2.
Obes Surg ; 34(1): 123-127, 2024 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-37914885

RESUMO

AIMS: Our aim was to assess, in obese patients undergoing Roux-en Y gastric bypass surgery, the bismuth quadruple therapy (BQT) eradication rates at the first-line Helicobacter pylori (Hp) treatment as proposed by the Maastricht V/Florence consensus in areas with high clarithromycin (CLT) resistance rates-10 days proton pump inhibitor bid and three-in-one single capsule bismuth therapy containing bismuth, metronidazole, and tetracycline, marketed as Pylera four times a day. METHODS: This is a single-center prospective study over a 3-year period. Endoscopy and Hp assessment by histology was performed at baseline, and posttreatment Hp status was assessed by C13 urea breath test 4-6 weeks after the end of therapy. Data analysis was performed using the IBM® SPSS® Statistics 28.0 (IBM Corp. 2021, Armonk, NY) using mostly nonparametric comparisons (α = 0.05). RESULTS: The study cohort consisted of 598 adult obese Hp-positive patients [476, 78.6% female, age 43.2 (± 10.4) years] consecutively scheduled for Hp eradication therapy. Hp was eradicated in 500 patients [83.6.3% (95% CI: 80.4%-86.5%)], and the eradication was independent of gender, age, endoscopic diagnosis, and smoking status (p > 0.05). CONCLUSION: Ten days of BQT did achieve Maastricht V/Florence recommended first-line eradication rates (at least 80%) in obese Portuguese patients undergoing Roux-en Y gastric bypass, being by now the most reliable choice for Hp eradication.


Assuntos
Derivação Gástrica , Infecções por Helicobacter , Helicobacter pylori , Obesidade Mórbida , Adulto , Humanos , Feminino , Masculino , Bismuto/uso terapêutico , Bismuto/efeitos adversos , Infecções por Helicobacter/tratamento farmacológico , Estudos Prospectivos , Obesidade Mórbida/cirurgia , Quimioterapia Combinada , Antibacterianos/uso terapêutico , Claritromicina/uso terapêutico , Tetraciclina/efeitos adversos , Metronidazol/uso terapêutico , Obesidade/complicações , Obesidade/tratamento farmacológico , Obesidade/cirurgia , Inibidores da Bomba de Prótons/uso terapêutico , Amoxicilina/uso terapêutico
3.
Adv Ther ; 40(4): 1366-1378, 2023 04.
Artigo em Inglês | MEDLINE | ID: mdl-36763302

RESUMO

Tetracyclines are a class of broad-spectrum bacteriostatic antibiotics used to treat many infections, including methicillin-resistant Staphylococcus aureus (MRSA), acne, pelvic inflammatory disease, chlamydial infections, and a host of zoonotic infections. These drugs work by inhibiting protein synthesis in bacterial ribosomes, specifically by disallowing aminoacyl-tRNA molecules from binding to the ribosomal acceptor sites. While rare, tetracycline antibiotics, particularly minocycline and doxycycline, are associated with an increased risk of developing esophageal perforation and pseudotumor cerebri (PTC, or idiopathic intracranial hypertension). Since tetracyclines are a commonly prescribed class of medications, especially in adolescents for acne treatment, it is important for clinicians to appreciate significant side effects that can result in morbidity and mortality. This paper aims to consolidate and to emphasize current research on the association between tetracycline antibiotics and the development of esophageal perforation, and PTC. PTC is a neurological syndrome consisting of increased intracranial pressure, headache, and vision changes without evidence of the contributing source, such as mass lesion, infection, stroke, or malignancy. Esophageal perforation, while rare, can be the result of pill esophagitis. Pill-induced injuries occur when caustic medicinal pills dissolve in the esophagus rather than in the stomach. Most patients experience only self-limited pain (retrosternal burning discomfort, heartburn, dysphagia, or odynophagia), but hemorrhage, stricture, and perforation may occur. Tetracycline use can lead to pill esophagitis. In summary, clinicians should appreciate the potential risks of tetracycline compounds in clinical practice.


Assuntos
Acne Vulgar , Perfuração Esofágica , Esofagite , Staphylococcus aureus Resistente à Meticilina , Pseudotumor Cerebral , Adolescente , Humanos , Minociclina/efeitos adversos , Doxiciclina/efeitos adversos , Tetraciclina/efeitos adversos , Pseudotumor Cerebral/induzido quimicamente , Pseudotumor Cerebral/tratamento farmacológico , Perfuração Esofágica/induzido quimicamente , Perfuração Esofágica/tratamento farmacológico , Antibacterianos/efeitos adversos , Acne Vulgar/induzido quimicamente , Acne Vulgar/tratamento farmacológico , Esofagite/induzido quimicamente , Esofagite/tratamento farmacológico , Dor/tratamento farmacológico
4.
J Neuroophthalmol ; 42(3): 323-327, 2022 09 01.
Artigo em Inglês | MEDLINE | ID: mdl-35427251

RESUMO

BACKGROUND: To determine whether the use of a tetracycline-class antibiotic is associated with an increased risk of developing pseudotumor cerebri syndrome (PTCS). METHODS: We identified patients in the University of Utah Health system who were prescribed a tetracycline-class antibiotic and determined what percentage of those individuals were subsequently diagnosed with PTCS secondary to tetracycline use. We compared this calculation to the number of patients with PTCS unrelated to tetracycline use. RESULTS: Between 2007 and 2014, a total of 960 patients in the University system between the ages of 12 and 50 were prescribed a tetracycline antibiotic. Among those, 45 were diagnosed with tetracycline-induced PTCS. We estimate the incidence of tetracycline-induced PTCS to be 63.9 per 100,000 person-years. By comparison, the incidence of idiopathic intracranial hypertension (IIH) is estimated to be less than one per 100,000 person-years (Calculated Risk Ratio = 178). CONCLUSIONS: Although a causative link between tetracycline use and pseudotumor cerebri has yet to be firmly established, our study suggests that the incidence of pseudotumor cerebri among tetracycline users is significantly higher than the incidence of IIH in the general population.


Assuntos
Pseudotumor Cerebral , Adolescente , Adulto , Antibacterianos/efeitos adversos , Criança , Humanos , Incidência , Pessoa de Meia-Idade , Pseudotumor Cerebral/induzido quimicamente , Pseudotumor Cerebral/complicações , Pseudotumor Cerebral/epidemiologia , Tetraciclina/efeitos adversos , Adulto Jovem
5.
Plast Reconstr Surg ; 146(6): 737e-743e, 2020 12.
Artigo em Inglês | MEDLINE | ID: mdl-33234952

RESUMO

BACKGROUND: The purpose of this study was to evaluate the long-term patient experience with tetracycline injections for treatment of festoons. METHODS: Charts of all patients undergoing tetracycline injection for treatment of lower eyelid festoons at the Cole Eye Institute, Cleveland Clinic, between 2008 and 2018 were identified using billing records. Patients were invited to participate in a questionnaire based on the FACE-Q checklist, a previously validated questionnaire for studying cosmetic procedure outcomes. Data from the questionnaire were summarized with size, mean, and frequency. RESULTS: One hundred two patients who received tetracycline injection during the study period were identified and 61 responses were obtained. The average follow-up time after injection was 3.6 years. Of 61 respondents, 36 (59 percent) noted improvement in their festoons after treatment, and 27 of 33 (82 percent) noted that improvement occurred within 2 months of treatment. Overall, 40 of 60 respondents (67 percent) would consider repeating tetracycline treatment. The most common adverse effects included discomfort (18 percent), swelling (15 percent), and bruising (13 percent). There was no statistically significant difference in questionnaire responses between men and women, except that men were more likely to consider repeated injection (92 percent versus 58 percent; p = 0.005). CONCLUSION: Tetracycline injection appears to improve festoons in a majority of patients, with an acceptable side-effect profile, although more data are needed to determine the optimal dose and frequency and to identify possible rare and/or significant side effects.


Assuntos
Músculos Faciais/efeitos dos fármacos , Ritidoplastia/métodos , Soluções Esclerosantes/administração & dosagem , Tetraciclina/administração & dosagem , Idoso , Idoso de 80 Anos ou mais , Feminino , Seguimentos , Humanos , Injeções Intralesionais/efeitos adversos , Masculino , Pessoa de Meia-Idade , Ritidoplastia/efeitos adversos , Tetraciclina/efeitos adversos , Resultado do Tratamento
6.
Am J Ophthalmol ; 220: 177-182, 2020 12.
Artigo em Inglês | MEDLINE | ID: mdl-32738227

RESUMO

PURPOSE: Comparisons between clinical features of tetracycline-induced pseudotumor cerebri (PTC-T) and those of idiopathic intracranial hypertension (IIH) are absent in the literature. We hypothesized that significant clinical differences between these etiologies exist and could be better understood by retrospective analysis. DESIGN: Retrospective cohort study. METHODS: We reviewed patients diagnosed with pseudotumor cerebri syndrome (PTCS) at our center and identified those who developed PTC-T after treatment with a tetracycline-class antibiotic and those with IIH. Groups were compared by demographics, body mass index, ophthalmic examination, treatment, clinical course, and visual outcomes. RESULTS: We identified 52 cases of PTC-T and 302 cases of IIH. Obesity rates were significantly different (43.8% for PTC-T vs 79.2% for IIH, P < .001). The mean age at diagnosis was younger for PTC-T (19.8 years vs 28.1 years for IIH, P < .001). Diplopia was more common with PTC-T (40.4% vs 20.1% for IIH, P = .001). The mean illness duration was shorter for PTC-T (18.3 weeks vs 62.9 weeks for IIH, P <.0001). Recurrence rates were significantly different (4.0% for PTC-T vs 16.5% for IIH, P <.001). The frequency of surgical intervention was similar. Vision loss was uncommon but occurred with similar frequency. CONCLUSION: We identified significant clinical differences but also identified important similarities between the 2 groups. There appear to be nonobese patients who develop PTC-T, discontinue the antibiotic, and never develop PTCS again. There are other patients who develop PTC-T, discontinue the antibiotic, and later develop IIH. We conclude that PTC-T represents a spectrum of disease in susceptible individuals.


Assuntos
Diagnóstico por Imagem/métodos , Pseudotumor Cerebral/induzido quimicamente , Tetraciclina/efeitos adversos , Adolescente , Adulto , Antibacterianos/efeitos adversos , Índice de Massa Corporal , Criança , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Pseudotumor Cerebral/diagnóstico , Estudos Retrospectivos , Adulto Jovem
7.
J Cell Biol ; 219(7)2020 07 06.
Artigo em Inglês | MEDLINE | ID: mdl-32428200

RESUMO

Spatiotemporally regulated targeted gene manipulation is a common way to study the effect of gene variants on phenotypic traits, but the Cre/loxP and Tet-On/Tet-Off systems can affect whole-organism physiology and function due to off-target effects. We highlight some of these adverse effects, including whole-body endocrinology and disturbances in the gut microbiome and in mitochondrial and metabolic function.


Assuntos
Artefatos , Sistemas CRISPR-Cas , Edição de Genes/métodos , Genoma , Elementos de Resposta/efeitos dos fármacos , Animais , Doxiciclina/efeitos adversos , Regulação da Expressão Gênica , Integrases/genética , Integrases/metabolismo , Camundongos , Camundongos Transgênicos , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/metabolismo , Receptores de Estrogênio/genética , Receptores de Estrogênio/metabolismo , Tamoxifeno/efeitos adversos , Tetraciclina/efeitos adversos , Transfecção/métodos
8.
Sci Rep ; 10(1): 8804, 2020 05 29.
Artigo em Inglês | MEDLINE | ID: mdl-32472015

RESUMO

To evaluate the micro-ecological effects of tetracycline residues on tobacco soil, high-throughput sequencing technology was used to study the effects of the addition of different concentrations (0, 5, 50, and 500 mg·kg-1) of tetracycline on the abundance, diversity, and structure of bacterial and fungal communities in the rhizosphere and non-rhizosphere soil of flue-cured tobacco in China. Results showed that the presence of tetracycline had an important but varying effect on soil bacterial and fungal community richness, diversity, and structure. Changes in the diversity indices (Chao index and Shannon index) of soil bacterial and fungal communities showed a similar pattern after the addition of tetracycline; however, a few differences were found in the effects of tetracycline in the rhizosphere and non-rhizosphere soil, suggesting an evident rhizosphere-specific effect. The bacterial community at the phylum level in the rhizosphere closely clustered into one group, which might be the result of tobacco root secretions and rhizodeposition. Tetracycline showed a concentration-dependent effect on the soil bacterial community structure. The soil bacterial community structures observed after treatments with higher concentrations of tetracycline (50 and 500 mg·kg-1) were found to be closely related. Moreover, the effects of the treatments with higher concentrations of tetracycline, on the soil bacterial community at the phylum level, were different from those with lower concentrations of tetracycline (5 mg·kg-1), and CK treatments. This might have resulted from the induction of increasing selective pressure with increasing antibiotic concentration. Tetracycline continued to affect the soil bacterial community throughout the experiment. Tetracycline was found to have a varying impact on the community structure of soil fungi compared to that of soil bacteria, and the addition of an intermediate concentration of tetracycline (50 mg·kg-1) significantly increased the soil fungal diversity in the non-rhizosphere soil. The biological effects of tetracycline on the soil fungal community and the fungal-bacterial interactions, therefore, require further elucidation, warranting further research.


Assuntos
Bactérias/classificação , Fungos/classificação , Nicotiana/crescimento & desenvolvimento , Solo/química , Tetraciclina/efeitos adversos , Bactérias/efeitos dos fármacos , Bactérias/genética , Bactérias/isolamento & purificação , Biodiversidade , China , DNA Bacteriano/genética , DNA Fúngico/genética , Fungos/efeitos dos fármacos , Fungos/genética , Fungos/isolamento & purificação , Sequenciamento de Nucleotídeos em Larga Escala , Microbiota/efeitos dos fármacos , Filogenia , Raízes de Plantas/crescimento & desenvolvimento , Raízes de Plantas/microbiologia , Rizosfera , Análise de Sequência de DNA , Microbiologia do Solo , Nicotiana/microbiologia
9.
Scand J Gastroenterol ; 53(1): 1-7, 2018 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-29022402

RESUMO

AIM: The aim of this study was to critically assess all available evidence suggesting an association between antibiotic exposure and new onset of inflammatory bowel disease (IBD). MATERIALS AND METHODS: This systematic review was conducted according to the PRISMA statement and eligible studies were identified through search of PubMed, Embase and the Cochrane Library. Data on patient demographics, antibiotic exposure and confounding factors were analyzed. The Newcastle-Ottawa Scale (NOS) was used to assess the quality of eligible studies. RESULTS: A total of 15 observational studies (10 case control and five cohort) including 8748 patients diagnosed with IBD were systematically reviewed. Antibiotic exposure was mostly associated with Crohn's disease but not with ulcerative colitis. In particular, penicillin's, cephalosporins, metronidazole and fluoroquinolones were most commonly associated with the onset of Crohn's disease. The impact of tetracycline-family antibiotics on the pathogenesis of IBD was not clear. CONCLUSION: There may be an association between antibiotic exposure and the development of IBD; especially Crohn's disease. Even though, clinicians should be cautious when prescribing certain antibiotic regimens to patients with a strong family history of IBD, it should be emphasized that available data are not granular enough to reach any definitive conclusions.


Assuntos
Antibacterianos/efeitos adversos , Doença de Crohn/induzido quimicamente , Colite Ulcerativa , Doença de Crohn/epidemiologia , Fluoroquinolonas/efeitos adversos , Humanos , Metronidazol/efeitos adversos , Penicilinas/efeitos adversos , Risco , Tetraciclina/efeitos adversos
10.
Helicobacter ; 22(3)2017 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-28125857

RESUMO

BACKGROUND: Rising antibiotic resistance requires the evaluation of new and effective therapies. AIMS: To test the efficacy and safety of the new bismuth-containing quadruple therapy in patients infected with Helicobacter pylori. MATERIAL AND METHODS: Consecutive H. pylori-positive dyspeptic patients were enrolled, either naïve or with previous failure treatment. Patients were treated with Pylera® (three-in-one capsules containing bismuth subcitrate potassium 140 mg, metronidazole 125 mg, and tetracycline 125 mg) three capsules q.i.d. plus omeprazole 20 mg or esomeprazole 40 mg b.i.d. for 10 days. Eradication was confirmed using an urea breath test (at least 30 days after the end of treatment). Efficacy was assessed by UBT and safety by means of treatment-emergent adverse events. RESULTS: One hundred and thirty-one patients were included in the study: 42% of patients were naïve, and 58%, with previous failure treatment. H. pylori eradication was achieved in 124 patients (94.7%, 95% confidence intervals (CIs) 89.3-97.8) in ITT population. In the PP population, the percentage was 97.6% (95%, CIs 93.3-99.2). No difference in eradication rate was found either between naïve and previously treated patients (92.7% vs 96.0%, P=.383), or smoking and nonsmoking ones, or in patients taking omeprazole or esomeprazole. Treatment-emergent adverse events occurred in 35 patients (26.7%, 95% CIs 19.9-34.9). They were mild in all cases except in four, who discontinued the study due to diarrhea (three patients) and diffuse urticarial rush (one patient). CONCLUSIONS: Pylera® achieved a remarkable eradication rate in clinical practice, irrespective if it was used as first treatment or as a rescue therapy. Treatment-emergent adverse events were uncommon generally mild.


Assuntos
Antibacterianos/uso terapêutico , Bismuto/uso terapêutico , Infecções por Helicobacter/tratamento farmacológico , Helicobacter pylori/isolamento & purificação , Inibidores da Bomba de Prótons/uso terapêutico , Antibacterianos/efeitos adversos , Bismuto/efeitos adversos , Testes Respiratórios , Quimioterapia Combinada/efeitos adversos , Quimioterapia Combinada/métodos , Feminino , Humanos , Itália , Masculino , Metronidazol/efeitos adversos , Metronidazol/uso terapêutico , Pessoa de Meia-Idade , Estudos Prospectivos , Inibidores da Bomba de Prótons/efeitos adversos , Tetraciclina/efeitos adversos , Tetraciclina/uso terapêutico , Resultado do Tratamento , Ureia/análise
11.
Int J Cancer ; 140(8): 1828-1835, 2017 04 15.
Artigo em Inglês | MEDLINE | ID: mdl-28120338

RESUMO

Bisphosphonate, tetracycline and spironolactone use has been shown to increase gastro-oesophageal inflammation, an accepted risk factor for cancer. However, evidence of the effect of these medications on gastro-oesophageal cancer risk are mixed or missing entirely. Therefore, we conducted a nested case-control study using the Primary Care Clinical Information Unit Research (PCCIUR) database from Scotland. Cases with oesophageal or gastric cancer between 1999 and 2011 were matched to up to five controls based on age, gender, year of diagnosis and general practice. Medication use was ascertained using electronic prescribing records. Conditional logistic regression was used to calculate odds ratios (ORs) for the association between medication use and cancer risk after adjustment for comorbidities and other medication use. A similar proportion of gastro-oesophageal cancer cases received bisphosphonates (3.9% vs. 3.5%), tetracycline (6.0% vs. 6.0%) and spironolactone (1.4% vs. 1.1%) compared with the controls. The adjusted ORs for the association between gastro-oesophageal cancer and bisphosphonates, tetracycline and spironolactone were 1.05 (95% CI: 0.85, 1.31), 0.99 (95% CI: 0.84, 1.17) and 1.04 (95% CI: 0.73, 1.49). Further analysis revealed bisphosphonates were associated with increased oesophageal cancer risk (1.34, 95% CI: 1.03, 1.74) but reduced gastric cancer risk (0.71, 95% CI: 0.49, 1.03), although there was no obvious dose-response relationship. Overall, there is little evidence that the use of bisphosphonate, tetracycline or spironolactone is associated with increased risk of gastro-oesophageal cancer. Our findings should reassure GPs and patients that these widely-used medications are safe with respect to gastro-oesophageal cancer risk.


Assuntos
Neoplasias Esofágicas/epidemiologia , Inflamação/epidemiologia , Osteoporose/complicações , Neoplasias Gástricas/epidemiologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Difosfonatos/efeitos adversos , Difosfonatos/uso terapêutico , Neoplasias Esofágicas/induzido quimicamente , Neoplasias Esofágicas/patologia , Feminino , Humanos , Inflamação/induzido quimicamente , Inflamação/patologia , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Osteoporose/tratamento farmacológico , Fatores de Risco , Escócia , Espironolactona/efeitos adversos , Espironolactona/uso terapêutico , Estômago/efeitos dos fármacos , Estômago/patologia , Neoplasias Gástricas/induzido quimicamente , Neoplasias Gástricas/patologia , Tetraciclina/efeitos adversos , Tetraciclina/uso terapêutico
12.
Clin Gastroenterol Hepatol ; 14(2): 220-5.e1-3, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26404866

RESUMO

BACKGROUND & AIMS: Rosacea is an inflammatory skin disease. Case reports have shown rosacea as a comorbidity of inflammatory bowel disease (IBD), but no epidemiologic studies have examined rosacea and risk of subsequent IBD. The association between tetracycline use and risk of IBD was assessed, but this study produced limited findings. We examined the association between rosacea, use of tetracycline, and risk of incident Crohn's disease (CD) and ulcerative colitis (UC). METHODS: We analyzed data from 96,314 participants in the Nurses' Health Study II (1991-2011). Information on IBD was confirmed by medical review. Participants were asked in 2005 about their lifetime histories of clinician-diagnosed rosacea and year of diagnosis. Information on ever use of tetracycline was collected in 1993. RESULTS: During 1,856,587 person-years (1991-2011), we identified 149 cases of CD and 215 cases of UC. Rosacea was not associated with risk of UC. In contrast, rosacea was significantly associated with increased risk of subsequent CD (hazard ratio [HR], 2.20; 95% confidence interval [CI], 1.15-4.18), which appeared particularly stronger for a longer duration after a diagnosis of rosacea (Ptrend = .01). Tetracycline use was associated with increased risk of CD (HR, 1.56; 95% CI, 1.09-2.24) and UC (HR, 1.34; 95% CI, 1.00-1.80); there was a trend toward increased risk with increased duration of use (both Ptrend < .05) (1993-2011). CONCLUSIONS: On the basis of an analysis of data from the Nurses' Health Study II, ever use of tetracycline at baseline is associated with an increased risk of CD and UC. Personal history of rosacea is associated with an increased risk of only CD.


Assuntos
Antibacterianos/efeitos adversos , Antibacterianos/uso terapêutico , Doenças Inflamatórias Intestinais/epidemiologia , Rosácea/complicações , Rosácea/tratamento farmacológico , Tetraciclina/efeitos adversos , Tetraciclina/uso terapêutico , Adulto , Feminino , Humanos , Medição de Risco , Inquéritos e Questionários
13.
Toxicol Appl Pharmacol ; 289(1): 40-7, 2015 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-26344000

RESUMO

Drug-induced steatohepatitis is a rare form of liver injury known to be caused by only a handful of compounds. These compounds stimulate the development of steatohepatitis through their toxicity to hepatocyte mitochondria; inhibition of beta-oxidation, mitochondrial respiration, and/or oxidative phosphorylation. Other mechanisms discussed include the disruption of phospholipid metabolism in lysosomes, prevention of lipid egress from hepatocytes, targeting mitochondrial DNA and topoisomerase, decreasing intestinal barrier function, activation of the adenosine pathway, increasing fatty acid synthesis, and sequestration of coenzyme A. It has been found that the majority of compounds that induce steatohepatitis have cationic amphiphilic structures; a lipophilic ring structure with a side chain containing a cationic secondary or tertiary amine. Within the last decade, the ability of many chemotherapeutics to cause steatohepatitis has become more evident coining the term chemotherapy-associated steatohepatitis (CASH). The mechanisms behind drug-induced steatohepatitis are discussed with a focus on cationic amphiphilic drugs and chemotherapeutic agents.


Assuntos
Doença Hepática Induzida por Substâncias e Drogas/patologia , Fígado Gorduroso/patologia , Mitocôndrias Hepáticas/efeitos dos fármacos , Amiodarona/efeitos adversos , Animais , Camptotecina/efeitos adversos , Camptotecina/análogos & derivados , Modelos Animais de Doenças , Fígado Gorduroso/induzido quimicamente , Hepatócitos/efeitos dos fármacos , Hepatócitos/metabolismo , Humanos , Irinotecano , Metabolismo dos Lipídeos/efeitos dos fármacos , Fígado/efeitos dos fármacos , Fígado/metabolismo , Metotrexato/efeitos adversos , Mitocôndrias Hepáticas/patologia , Compostos Organoplatínicos/efeitos adversos , Oxaliplatina , Perexilina/efeitos adversos , Tamoxifeno/efeitos adversos , Tetraciclina/efeitos adversos , Ácido Valproico/efeitos adversos
14.
Clín. int. j. braz. dent ; 11(1): 52-60, jan.-mar.2015. ilus
Artigo em Português | LILACS | ID: lil-789780

RESUMO

A demanda por tratamentos estéticos que buscam um sorriso com aparência natural e com adequada longevidade clínica tem aumentado tanto por parte dos pacientes como por parte dos profissionais. O esclarecimento e a disponibilidade de novas técnicas fizeram surgir a preocupação por tratar esteticamente, no entanto mediante tratamentos minimamente invasivos, que não gerem danos à estrutura dental. Nesse contexto, surgiram os laminados cerâmicos minimamente invasivos. Este artigo relata um caso clínico de remodelação estética de dentes anteriores com manchamento por tetraciclina, através de laminados cerâmicos minimamente invasivos...


The demand for aesthetic treatments searching a natural-looking smile and longevity is increasing by patients and dentists. The knowledge and availability of new techniques increased the desire for aesthetic treatments that could be minimally invasive and not generating damage to tooth structure. In this context, minimally invasive ceramic laminates appeared. This paper reports the aesthetic reshaping of anterior teeth with tetracycline staining using minimally invasive ceramic laminates...


Assuntos
Humanos , Feminino , Adulto , Cerâmica , Porcelana Dentária , Estética Dentária , Sorriso , Tetraciclina/efeitos adversos
16.
Ther Adv Respir Dis ; 9(2): 42-8, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25663279

RESUMO

OBJECTIVES: Autologous blood pleurodesis (ABP) is used for the treatment of pneumothorax with a good efficacy. The aim of this study is to determine the efficacy and safety of ABP in the treatment of malignant pleural effusion (MPE). METHODS: A prospective study was conducted at Songklanagarind Hospital, Thailand. Symptomatic MPE patients were randomized to receive pleurodesis with either autologous blood or tetracycline. In the ABP group, 100 ml of autologous venous blood was instilled via chest tube followed by 50 ml of sterile normal saline (NSS). In the tetracycline group, 20 ml of 1% lidocaine diluted in 30 ml NSS was instilled followed by 1 g of tetracycline diluted in 100 ml of NSS. The chest tube was clamped for 2 hours, then reconnected to suction and removed. Pleurodesis effectiveness was evaluated according to Paladine's criteria and adverse events were recorded. RESULTS: A total of 48 symptomatic MPE patients were recruited. Of these, 24 cases were randomized to receive ABP and 24 cases received tetracycline. There was no difference between the two groups in baseline characteristics. The overall success rate of pleurodesis was the same in both the autologous blood group and the tetracycline group (83.4% versus 87.5%, p = 0.36). In the ABP group, the pain score and fever were significantly lower (8.3% versus 29.1%, p = 0.003) and there was a small percentage of cases that needed analgesia (4.2% versus 75%, p < 0.001); no serious events occurred. CONCLUSIONS: ABP was as effective as tetracycline in the treatment of MPE. ABP produced less pain and fever, and could shorten the hospital stay.


Assuntos
Sangue , Derrame Pleural Maligno/terapia , Pleurodese/métodos , Soluções Esclerosantes/uso terapêutico , Tetraciclina/administração & dosagem , Idoso , Autoenxertos , Feminino , Febre/etiologia , Febre/prevenção & controle , Humanos , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Dor/etiologia , Dor/prevenção & controle , Derrame Pleural Maligno/diagnóstico , Pleurodese/efeitos adversos , Estudos Prospectivos , Soluções Esclerosantes/efeitos adversos , Tetraciclina/efeitos adversos , Tailândia , Fatores de Tempo , Resultado do Tratamento
17.
Semin Diagn Pathol ; 31(2): 165-75, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24815941

RESUMO

Abnormalities of the gastrointestinal tract due to drug-induced injuries are common and often have important clinical consequences. Medications may cause damage by direct corrosive effects on mucosae or by alter processes, mucosal immunity, and local environmental conditions. The aim of this review is to guide practicing pathologists in the identification of drug-related injuries in gastrointestinal mucosal biopsies and resection specimens. Common causes of injury and their gross, endoscopic, and microscopic features are presented.


Assuntos
Gastroenteropatias/induzido quimicamente , Trato Gastrointestinal/patologia , Alendronato/efeitos adversos , Bloqueadores do Receptor Tipo 1 de Angiotensina II/efeitos adversos , Anti-Inflamatórios/efeitos adversos , Antineoplásicos Fitogênicos/efeitos adversos , Conservadores da Densidade Óssea/efeitos adversos , Resinas de Troca de Cátion/efeitos adversos , Colchicina/efeitos adversos , Compostos Ferrosos/efeitos adversos , Gastroenteropatias/patologia , Trato Gastrointestinal/efeitos dos fármacos , Supressores da Gota/efeitos adversos , Humanos , Imidazóis/efeitos adversos , Imunossupressores/efeitos adversos , Ácido Micofenólico/efeitos adversos , Ácido Micofenólico/análogos & derivados , Paclitaxel/efeitos adversos , Poliestirenos/efeitos adversos , Tetraciclina/efeitos adversos , Tetrazóis/efeitos adversos
19.
Ukr Biokhim Zh (1999) ; 85(5): 154-62, 2013.
Artigo em Ucraniano | MEDLINE | ID: mdl-24479333

RESUMO

The state of antioxidant system and fatty acid composition of lipids in the liver tissues of rats of different sex at the ethanol and tetracycline action and at the influence of biologically active additives (BAA) "Alpha + Omega" at a dose of 0.5 mg/kg b.w. per os was investigated. It was found that the contet of lipid peroxidation products in the liver was increased at the action of 40% ethanol at a dose of 7 ml/kg b.w. per os and tetracycline--500 mg/kg and more profound at their joint using. However, the content of diene conjugates was stronger increased in the liver of females at the action of ethanol, while in the liver of males at the action of tetracycline (P < 0.05). It was shown that the application of the investigated compounds led to the reduction of an antioxidant defense system activity of males and females liver, as evidenced by the decrease of superoxide dismutase activity by 46 and 43% and reduction of glutathione content by 39 and 38% (P < 0.05). The activity of alanineaminotransferase, aspartateaminotransferase and alkalinephosphatase was increased in the liver of males and females under the influence of ethanol and tetracycline and more profound at their joint usage (P < 0.05). It was established that ethanol and tetracycline unidirectionally changed fatty acid composition of total lipids of rat liver, but at the ethanol action the changes were more expressed in females while at the tetracycline action in males. The application during 14 days of BAA "Alpha + Omega" to male and female rats with an acute tetracycline damage at subacute ethanol action led to partial normalization of prooxidant-antioxidant system and the relative content of total lipids fatty acids of the liver of both sexes animals.


Assuntos
Etanol/efeitos adversos , Ácidos Graxos Ômega-3/administração & dosagem , Fígado/efeitos dos fármacos , Tetraciclina/efeitos adversos , Alanina Transaminase/metabolismo , Fosfatase Alcalina/metabolismo , Animais , Aspartato Aminotransferases/metabolismo , Catalase/metabolismo , Feminino , Glutationa/metabolismo , Glutationa Peroxidase/metabolismo , Peroxidação de Lipídeos/efeitos dos fármacos , Fígado/enzimologia , Fígado/patologia , Masculino , Estresse Oxidativo/efeitos dos fármacos , Ratos , Espécies Reativas de Oxigênio/agonistas , Espécies Reativas de Oxigênio/antagonistas & inibidores , Espécies Reativas de Oxigênio/metabolismo , Superóxido Dismutase/metabolismo
20.
Braz. dent. j ; 23(4): 403-408, 2012. ilus, tab
Artigo em Inglês | LILACS | ID: lil-658018

RESUMO

Dental ceramics present excellent ability to reproduce the natural teeth regarding esthetic and biomechanics. Recently, due to the advancement of ceramic technology, metal-free restorations were developed. However, the traditional metal-ceramic restorations still present the requirements of high strength, long survival in the oral environment and favorable aesthetics. In this context, it is essential to know the specificity of each ceramic system available in order to apply it properly to various clinical situations. This report describes an integrated rehabilitation using metal-ceramic restorations of a patient at 50 years of age, who presented edentulous spaces, and previous unsatisfactory composite and amalgam restorations, and indirect metallic restorations, leading to compromised quality of life in both functional and psychosocial aspects. The impact on quality of life was measured using a generic instrument, OHIP-14, validated for the World Health Organization, which covers both the biological and the psychosocial dimensions. This instrument was applied to the patient before and after treatment. The patient had an overall OHIP-14 score of 28 before the treatment and after treatment the score decreased to 0, showing that dental and oral health conditions are factors that do impact on the quality of life. Rehabilitation has provided functional and aesthetic restorations, harmony of the stomatognathic system and improvement of life quality.


As cerâmicas dentais são conhecidas pela excelência em reproduzir artificialmente dentes naturais. Recentemente, devido ao aprimoramento da tecnologia cerâmica, surgiram as restaurações livres de metal. Entretanto, as tradicionais metalocerâmicas ainda preenchem adequadamente os requisitos de alta resistência, longa sobrevida em meio bucal e estética favorável. Neste contexto, é fundamental conhecer a especificidade de cada sistema cerâmico a fim de indicá-lo adequadamente às diversas situações clínicas. Este artigo relata um caso de reabilitação integral e integrada de paciente de 50 anos de idade, portador de espaços edêntulos, restaurações protéticas posteriores e restaurações diretas anteriores insatisfatórias, resultando em comprometimento da qualidade de vida nos âmbitos funcional e psicossocial, utilizando coroas metalocerâmicas. O impacto na qualidade de vida foi mensurado utilizando um instrumento genérico, OHIP-14, validado pela Organização Mundial de Saúde, que abrange tanto a dimensão biológica, como a dimensão psicossocial. Este instrumento foi aplicado à paciente antes e após o tratamento, obtendo pontuação total de 28 e 0 respectivamente, o que mostra que a condição de saúde oral representa fator de grande impacto sobre a qualidade de vida. A reabilitação oral proporcionou restabelecimento funcional e estético, harmonia do sistema estomatognático e melhoria da qualidade de vida da paciente.


Assuntos
Feminino , Humanos , Pessoa de Meia-Idade , Porcelana Dentária/química , Planejamento de Dentadura/psicologia , Ligas Metalo-Cerâmicas/química , Reabilitação Bucal/psicologia , Saúde Bucal , Qualidade de Vida , Atitude Frente a Saúde , Antibacterianos/efeitos adversos , Falha de Restauração Dentária , Seguimentos , Dor Facial/reabilitação , Gengivoplastia/métodos , Planejamento de Assistência ao Paciente , Satisfação do Paciente , Sorriso , Retalhos Cirúrgicos/cirurgia , Tetraciclina/efeitos adversos , Descoloração de Dente/induzido quimicamente , Descoloração de Dente/reabilitação , Dimensão Vertical
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA